Drawing for METABOGENOMICS

USPTO serial 98286230

METABOGENOMICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
TMO LAW OFFICE 110

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with METABOGENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

DEVON E. WHITE WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL, SUITE 300RALEIGH, NC 27607UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research and drug development services for the purposes of biomarker discovery through the application of metabolomics; Scientific, clinical and pharmaceutical research and drug development services for the purposes of biomarker discovery through the application of metabolomics, namely, providing consultation and analysis in detection of small molecules, measuring metabolite levels, diagnosing disorders, identifying small molecule biochemical pathways and determining drug target attributes; Scientific, clinical and pharmaceutical research and drug development services for the purposes of biomarker discovery through the application of metabolomics, namely, providing consultation and analysis to provide metabolite identification and quantification including complex lipids, as well as metabolite panels and targeted assays; providing an internet website portal featuring both raw and interpreted data from metabolomics and lipidomic studies, featuring temporary use of non-downloadable software for visualizing the data and for accessing knowledge-based articles, annotations, and information on known metabolites, as well as allowing users to upload raw and interpreted data; providing an on-line searchable database featuring science-related information about metabolites; Providing scientific information in the field of lipid metabolism to others that results from the organization, visualization and analysis of lipid metabolite data from an online computer database; quantitative analysis of metabolites; scientific research and laboratory research in the field of metabolic biochemistry; providing temporary use of on-line, non-downloadable software for generating visualizations of datasets; providing temporary use of online, non-downloadable software for generating visualizations of datasets in the fields of life sciences and healthcare; providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reportsACTIVENov 15, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 21, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 21, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 7, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2024DOCKASSIGNED TO EXAMINER—
Jan 18, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance